Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Cancers of the kidney: multiple drug resistance].

Bulletin du cancer - 1 Oct 1993

Oudard S, Lizard G, Roignot P, Poupon M F

Abstract excerpt

The treatment of kidney cancers raise difficult problems. Usual treatments combining surgery, radiation therapy, chemotherapy and hormonotherapy are poorly effective. The immunotherapy gave only an objective response rate of 25% in metastatic renal cell carcinomas. Among cellular resistance mechanisms of renal carcinoma, the multi-drug resistance (MDR) phenotype and the glutathione redox cycle have been studied....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carrier Proteins
Share to Drug Resistance
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glutathione Transferase

Share to Kidney Neoplasms

Share to Membrane Glycoproteins

Share to Neoplasm Proteins

Share to Phenotype

Source

Identifiers

PMID: 7911345

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Cancers of the kidney: multiple drug resistance].PMID 7911345Read ↗

[MDR (Multiple Drug Resistant) type of resistance to chemotherapy in clinical practice].Semantic proximity Read ↗

[Multiple drug resistance].Semantic proximity Read ↗

[Resistance to anticancer drugs].Semantic proximity Read ↗

[Resistance to chemotherapy: current progress].Semantic proximity Read ↗

[Multidrug or pleiotropic resistance].Semantic proximity Read ↗

[MDR (multidrug resistance) in hepatocarcinoma clinical-therapeutic implications].Semantic proximity Read ↗

[Multiple drug resistance--theoretical and clinical aspects].Semantic proximity Read ↗

[Multidrug resistance of malignant tumors].Semantic proximity Read ↗

Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug TreatmentSemantic proximity Read ↗

General Mechanisms of Resistance to Pharmacological Therapy Applied to Tumor CellsSemantic proximity Read ↗

Multidrug Resistance in Cancer: Its Mechanism and its ModulationSemantic proximity Read ↗

[MDR1 (ABCB1) gene encoding glycoprotein P (P-gp), a member of ABC transporter superfamily: consequences for therapy and progression of neoplastic diseases].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.